| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5cd84f92e5e2ff95dfd19e4e329db3b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate |
2014-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd243dc2e9ce9379c20a6803414238c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c8f9eaca53e9a1fad01070dd99318c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4cf9094999867ff50642cbf3d8eec26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51417341bc0da90f52ef788a8d2c52d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76d91eb3b078cd20ea7bf9a77c78a794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32a26b4d778c44aa060164084d708f96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e2e2e9ca9d5d016ebbf9f0e84cda2e1 |
| publicationDate |
2015-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201529602-A |
| titleOfInvention |
Monoclonal antibody against antithrombin beta |
| abstract |
This patent document relates to antibodies against human antithrombin beta (ATβH) complexed with heparin and/or heparin-like structures, antigen-binding antibody fragments (Fabs), and other protein scaffolds. These ATβH binding proteins block the anticoagulant activity of ATβ to induce coagulation. The therapeutic uses of these antibodies and binding agents as well as methods of panning and screening for specific antibodies are described herein. |
| priorityDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |